Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Acasti Pharma Inc

ACST
Current price
3.34 USD +0.22 USD (+7.05%)
Last closed 3.3 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 31 018 020 USD
Yield for 12 month +481.27 %
1Y
3Y
5Y
10Y
15Y
ACST
21.11.2021 - 28.11.2021

Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Address: 3009 boulevard de la Concorde East, Laval, QC, Canada, H7E 2B5

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.98 USD

P/E ratio

Dividend Yield

Current Year

Last Year

+9 635 USD

Current Quarter

Last Quarter

Current Year

-38 653 519 USD

Last Year

-11 553 441 USD

Current Quarter

-2 255 252 USD

Last Quarter

-1 550 439 USD

Key Figures ACST

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -12 211 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -7.92 %
PEG Ratio
Return On Equity TTM -48.05 %
Wall Street Target Price 5.98 USD
Revenue TTM 115 000 USD
Book Value 6.88 USD
Revenue Per Share TTM 0.005 USD
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 120 000 USD
Earnings Share -5.68 USD
Diluted Eps TTM -5.68 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ACST

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ACST

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:6
Payout Ratio
Last Split Date 10.07.2023
Dividend Date

Stock Valuation ACST

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 5.5008
Price Sales TTM 208.3872
Enterprise Value EBITDA -0.4839
Price Book MRQ 0.4796

Financials ACST

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ACST

For 52 weeks

1.72 USD 3.9 USD
50 Day MA 2.5 USD
Shares Short Prior Month 19 546
200 Day MA 2.55 USD
Short Ratio 1.03
Shares Short 23 634
Short Percent 0.28 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

402.79 USD Microsoft Corporation -0.45 (-0.11%)
Detailed analytics

ETF funds


S

SX7EEX

11.59 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2031.07 USD Gold +9.2 (+0.46%)
Detailed analytics